Biodefense start-up companies have an abundance of options when seeking funding.
Sandy Weinberg, PhD
Advertisement
Sandy Weinberg, PhD, is an associate professor of healthcare management at Clayton State University
Articles by Sandy Weinberg, PhD
Advertisement
Latest Updated Articles
Funding Biodefense Vaccine DevelopmentApril 1st 2009
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
3
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
4
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
5